TrialInternational journal of hematology2017

Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms.

Yasuhiro Taniguchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.